• Daniela Ruah posted an update in the group Group logo of ProductProduct 2 weeks, 1 day ago

    The US FDA, Pending The Clinical Benefit Study, Has Conditionally Approved The First New Alzheimer’s Disease Drug, Since A Drug Was Last Approved In Almost 20 Years, In 2003. The Novel Experimental Drug, Known As Aducanumab Or Aduhelm, Is Intended For Patients With Earliest Stage Of Dementia, And To Slow Alzheimer’s Disease Progression.

About us   |  FAQ  |  Contact us   |  Copyright ©2021  DiscoveryBit.com  |   Privacy  |   Terms of Service

   
Do NOT follow this link or you will be banned from the site! This is a social network for those interested in unique and valuable information!

Log in with your credentials

or    

Forgot your details?

Create Account